{"transactions":[{"id":3327,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Common shares without par value","published_at":"2026-09-03T22:02:03.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":388,"price":110.36,"value":42819.68,"ownership":{"direct":true},"balance_after":70784,"source":{"system":"sec-edgar","filing":"0001805099-26-000008","document":"form4-09032026_100959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805099/000180509926000008/form4-09032026_100959.xml","form_type":"4"}},{"id":310336,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Common shares without par value","published_at":"2026-04-27T21:34:47.000Z","date":"2026-04-23","kind":"purchase","planned":false,"acquired":true,"shares":2200,"price":91.5,"value":201300.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":2200,"source":{"system":"sec-edgar","filing":"0001805099-26-000006","document":"form4-04272026_090443.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000180509926000006/form4-04272026_090443.xml","form_type":"4"}},{"id":310335,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Common shares without par value","published_at":"2026-04-27T21:34:47.000Z","date":"2026-04-23","kind":"other","planned":false,"acquired":true,"shares":8909,"price":92.04,"value":819984.36,"ownership":{"direct":false,"nature":"Profit Sharing Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Balance in the Abbott Laboratories Stock Retirement Trust as of April 23, 2026."}],"balance_after":9276,"source":{"system":"sec-edgar","filing":"0001805099-26-000006","document":"form4-04272026_090443.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000180509926000006/form4-04272026_090443.xml","form_type":"4"}},{"id":312195,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Common shares without par value","published_at":"2026-03-04T00:34:03.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":7441,"price":116.26,"value":865090.66,"ownership":{"direct":true},"balance_after":71172,"source":{"system":"sec-edgar","filing":"0001805099-26-000004","document":"form4-03042026_120355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000180509926000004/form4-03042026_120355.xml","form_type":"4"}},{"id":312697,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Option (right to buy)","published_at":"2026-02-26T22:46:33.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":115413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 38,471 on February 24, 2027, 38,471 on February 24, 2028, and 38,471 on February 24, 2029."}],"balance_after":115413,"derivative":{"exercise_price":114.6,"exercise_date":"2027-02-24","expiration_date":"2036-02-23","underlying":"Common Shares","underlying_shares":115413},"source":{"system":"sec-edgar","filing":"0001805099-26-000002","document":"form4-02262026_100226.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000180509926000002/form4-02262026_100226.xml","form_type":"4"}},{"id":312696,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Common shares without par value","published_at":"2026-02-26T22:46:33.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":27997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":78613,"source":{"system":"sec-edgar","filing":"0001805099-26-000002","document":"form4-02262026_100226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000180509926000002/form4-02262026_100226.xml","form_type":"4"}},{"id":319106,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Common shares without par value","published_at":"2025-09-03T21:31:26.000Z","date":"2025-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":387,"price":132.66,"value":51339.42,"ownership":{"direct":true},"balance_after":50616,"source":{"system":"sec-edgar","filing":"0001415889-25-023586","document":"form4-09032025_090923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925023586/form4-09032025_090923.xml","form_type":"4"}},{"id":319975,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Common shares without par value","published_at":"2025-08-11T21:53:04.000Z","date":"2025-08-08","kind":"sale","planned":false,"acquired":false,"shares":5550,"price":134.551,"value":746758.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.551 to $134.58, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":51003,"source":{"system":"sec-edgar","filing":"0001415889-25-021451","document":"form4-08112025_090800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925021451/form4-08112025_090800.xml","form_type":"4"}},{"id":324621,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Common shares without par value","published_at":"2025-03-05T00:21:09.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":4908,"price":135.87,"value":666849.96,"ownership":{"direct":true},"balance_after":56553,"source":{"system":"sec-edgar","filing":"0001415889-25-006741","document":"form4-03052025_120306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925006741/form4-03052025_120306.xml","form_type":"4"}},{"id":325053,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2025-02-27T22:46:56.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":83783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,927 on February 25, 2026, 27,928 on February 25, 2027, and 27,928 on February 25, 2028."}],"balance_after":83783,"derivative":{"exercise_price":135.42,"exercise_date":"2026-02-25","expiration_date":"2035-02-24","underlying":"Common Shares","underlying_shares":83783},"source":{"system":"sec-edgar","filing":"0001415889-25-005885","document":"form4-02272025_100252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925005885/form4-02272025_100252.xml","form_type":"4"}},{"id":325052,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-02-27T22:46:56.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":22495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":61461,"source":{"system":"sec-edgar","filing":"0001415889-25-005885","document":"form4-02272025_100252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925005885/form4-02272025_100252.xml","form_type":"4"}},{"id":330910,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2024-09-05T00:03:07.000Z","date":"2024-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":387,"price":113.27,"value":43835.49,"ownership":{"direct":true},"balance_after":38966,"source":{"system":"sec-edgar","filing":"0001415889-24-022823","document":"form4-09042024_100951.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924022823/form4-09042024_100951.xml","form_type":"4"}},{"id":338510,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2024-03-04T23:44:32.000Z","date":"2024-02-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":1738,"price":120.05,"value":208646.9,"ownership":{"direct":true},"balance_after":39353,"source":{"system":"sec-edgar","filing":"0001415889-24-006402","document":"form4-03042024_110324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924006402/form4-03042024_110324.xml","form_type":"4"}},{"id":339302,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2024-02-23T22:23:34.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":86519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 28,839 on February 21, 2025, 28,840 on February 21, 2026, and 28,840 on February 21, 2027."}],"balance_after":86519,"derivative":{"exercise_price":116.98,"exercise_date":"2025-02-21","expiration_date":"2034-02-20","underlying":"Common Shares","underlying_shares":86519},"source":{"system":"sec-edgar","filing":"0001415889-24-005080","document":"form4-02232024_100223.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924005080/form4-02232024_100223.xml","form_type":"4"}},{"id":339301,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2024-02-23T22:23:34.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":23024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":41091,"source":{"system":"sec-edgar","filing":"0001415889-24-005080","document":"form4-02232024_100223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924005080/form4-02232024_100223.xml","form_type":"4"}},{"id":345949,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2023-09-06T22:53:23.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":10223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 3,407 on September 1, 2024, 3,408 on September 1, 2025, and 3,408 on September 1, 2026."}],"balance_after":10223,"derivative":{"exercise_price":103.18,"exercise_date":"2024-09-01","expiration_date":"2033-08-31","underlying":"Common Shares","underlying_shares":10223},"source":{"system":"sec-edgar","filing":"0001415889-23-013036","document":"form4-09062023_100916.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923013036/form4-09062023_100916.xml","form_type":"4"}},{"id":345948,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-09-06T22:53:23.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":2620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":18067,"source":{"system":"sec-edgar","filing":"0001415889-23-013036","document":"form4-09062023_100916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923013036/form4-09062023_100916.xml","form_type":"4"}},{"id":348187,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-06-20T22:55:49.000Z","date":"2023-06-16","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":106,"value":848000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale transaction was made pursuant to a Rule 10b5-1(c) plan adopted on February 24, 2023."}],"balance_after":15447,"source":{"system":"sec-edgar","filing":"0001415889-23-010065","document":"form4-06202023_100642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923010065/form4-06202023_100642.xml","form_type":"4"}},{"id":352021,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-03-03T00:19:15.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":1477,"price":99.77,"value":147360.29,"ownership":{"direct":true},"balance_after":23447,"source":{"system":"sec-edgar","filing":"0001415889-23-003894","document":"form4-03032023_120354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003894/form4-03032023_120354.xml","form_type":"4"}},{"id":352768,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2023-02-22T23:38:50.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":19149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 6,383 on February 17, 2024, 6,383 on February 17, 2025, and 6,383 on February 17, 2026."}],"balance_after":19149,"derivative":{"exercise_price":106.24,"exercise_date":"2024-02-17","expiration_date":"2033-02-16","underlying":"Common Shares","underlying_shares":19149},"source":{"system":"sec-edgar","filing":"0001415889-23-003046","document":"form4-02222023_110238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003046/form4-02222023_110238.xml","form_type":"4"}},{"id":352767,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-02-22T23:38:50.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":4855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":24924,"source":{"system":"sec-edgar","filing":"0001415889-23-003046","document":"form4-02222023_110238.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003046/form4-02222023_110238.xml","form_type":"4"}},{"id":364714,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-03-03T00:31:17.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":1192,"price":122.41,"value":145912.72,"ownership":{"direct":true},"balance_after":20069,"source":{"system":"sec-edgar","filing":"0001415889-22-002186","document":"form4-03022022_040307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922002186/form4-03022022_040307.xml","form_type":"4"}},{"id":365300,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2022-02-24T01:00:36.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":24938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 8,312 on February 18, 2023, 8,313 on February 18, 2024, and 8,313 on February 18, 2025."}],"balance_after":24938,"derivative":{"exercise_price":117.58,"exercise_date":"2023-02-18","expiration_date":"2032-02-17","underlying":"Common Shares","underlying_shares":24938},"source":{"system":"sec-edgar","filing":"0001415889-22-001730","document":"form4-02232022_050218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001730/form4-02232022_050218.xml","form_type":"4"}},{"id":365299,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-02-24T01:00:36.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":966,"price":116.79,"value":112819.14,"ownership":{"direct":true},"balance_after":21261,"source":{"system":"sec-edgar","filing":"0001415889-22-001730","document":"form4-02232022_050218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001730/form4-02232022_050218.xml","form_type":"4"}},{"id":365298,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-02-24T01:00:36.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":5351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":22227,"source":{"system":"sec-edgar","filing":"0001415889-22-001730","document":"form4-02232022_050218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001730/form4-02232022_050218.xml","form_type":"4"}},{"id":370151,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-10-27T22:22:14.000Z","date":"2021-10-25","kind":"sale","acquired":false,"shares":8000,"price":126.49,"value":1011920.0,"ownership":{"direct":true},"balance_after":16876,"source":{"system":"sec-edgar","filing":"0001415889-21-004996","document":"form4-10272021_031057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921004996/form4-10272021_031057.xml","form_type":"4"}},{"id":379030,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-03-02T23:59:10.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":704,"price":121.58,"value":85592.32,"ownership":{"direct":true},"balance_after":24876,"source":{"system":"sec-edgar","filing":"0001415889-21-001197","document":"form4-03022021_030354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921001197/form4-03022021_030354.xml","form_type":"4"}},{"id":379676,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2021-02-23T23:24:41.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":25613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 8,537 on February 19, 2022, 8,538 on February 19, 2023, and 8,538 on February 19, 2024."}],"balance_after":25613,"derivative":{"exercise_price":124.04,"exercise_date":"2022-02-19","expiration_date":"2031-02-18","underlying":"Common Shares","underlying_shares":25613},"source":{"system":"sec-edgar","filing":"0001415889-21-000885","document":"form4-02232021_030207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000885/form4-02232021_030207.xml","form_type":"4"}},{"id":379675,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-02-23T23:24:41.000Z","date":"2021-02-22","kind":"tax_withholding","acquired":false,"shares":937,"price":123.04,"value":115288.48,"ownership":{"direct":true},"balance_after":25580,"source":{"system":"sec-edgar","filing":"0001415889-21-000885","document":"form4-02232021_030207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000885/form4-02232021_030207.xml","form_type":"4"}},{"id":379674,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-02-23T23:24:41.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":4997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":26517,"source":{"system":"sec-edgar","filing":"0001415889-21-000885","document":"form4-02232021_030207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000885/form4-02232021_030207.xml","form_type":"4"}},{"id":379929,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-02-18T22:51:39.000Z","date":"2021-02-16","kind":"tax_withholding","acquired":false,"shares":943,"price":128.23,"value":120920.89,"ownership":{"direct":true},"balance_after":21520,"source":{"system":"sec-edgar","filing":"0001415889-21-000750","document":"form4-02182021_020216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000750/form4-02182021_020216.xml","form_type":"4"}},{"id":392993,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common shares without par value","published_at":"2020-03-16T22:47:12.000Z","date":"2020-03-13","kind":"sale","acquired":false,"shares":10600,"price":82,"value":869200.0,"ownership":{"direct":true},"balance_after":22463,"source":{"system":"sec-edgar","filing":"0001179110-20-003729","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020003729/edgar.xml","form_type":"4"}}]}